# Azithromycin (FTA) — Azithromycin (FTA) — Cefuroxim (FTA, TAB, UTA) — Cefuroxim (FTA, TAB, UTA) — Doxycyclin (FTA, HKP, TAB) — Doxycyclin (FTA, HKP, TAB) — Fusidinsäure + Betamethason (CRE) — Fusidinsäure + Betamethason (CRE) — Moxifloxacin (FTA) — Moxifloxacin (FTA) — Ofloxacin (ATR, AUS, KPG) — Ofloxacin (ATR, AUS, KPG)

Abschluss eines Generikarabattvertrags für den o.  g.  Wirkstoff.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/azithromycin-fta-azithromycin-fta-cefuroxim-fta-tab-uta-cefuroxim-fta--725aa782-62bf-4f26-9233-21ad87330320
Last checked by QUOTA: 2026-10-16
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Allemagne [FACT]
- Deadline: 2026-11-25 [FACT]
- Last checked by QUOTA: 2026-10-16 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Allemagne
- funder: GWQ ServicePlus AG
- buyer: GWQ ServicePlus AG

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.